An emerging role for TARPs in neuropsychiatric disorders.
Neuroscience Discovery Research, Eli Lilly and Company, Indianapolis, IN, USA. gill_martin_b@lilly.com
Martin B
MB
Gill
David S
DS
Bredt
D000818:Animals; D001923:Brain Chemistry / Q000235:genetics / Q000502:physiology*; D015220:Calcium Channels / Q000235:genetics / Q000502:physiology*; D005786:Gene Expression Regulation / Q000502:physiology; D020022:Genetic Predisposition to Disease / Q000235:genetics; D018698:Glutamic Acid / Q000235:genetics / Q000502:physiology*; D006801:Humans; D051379:Mice; D019965:Neurocognitive Disorders / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D021122:Protein Subunits / Q000235:genetics / Q000502:physiology; D018091:Receptors, AMPA / Q000235:genetics / Q000502:physiology*
C113940:Cacng2 protein, mouse; D015220:Calcium Channels; D021122:Protein Subunits; D018091:Receptors, AMPA; D018698:Glutamic Acid